Literature DB >> 15934971

Venous mapping using venography and the risk of radiocontrast-induced nephropathy.

Arif Asif1, Gautam Cherla, Donna Merrill, Cristian D Cipleu, Jan Bijan Tawakol, David L Epstein, Oliver Lenz.   

Abstract

Venous mapping using venography has been considered to be the gold standard for identifying veins suitable for arteriovenous fistula (AVF) creation. By utilizing a radiocontrast medium, however, venography introduces the risk of radiocontrast-induced nephropathy. The risk of this complication in the chronic kidney disease (CKD) population has not been previously studied. Twenty-five consecutive patients (CKD stage 4 and 5) undergoing venography were enrolled in this study. Patients were advised not to fast for the procedure and were encouraged to take oral fluids. Radiocontrast-induced nephropathy was defined as a 20% decrease in the estimated glomerular filtration rate (GFR) from the baseline value at 48 hours after contrast administration. Weekly telephone calls were made for a total of 4 weeks to assess the need for dialysis. Venography was performed by interventional nephrology using 10-20 cc of low osmolarity contrast medium. Data were collected prospectively. Median age was 48.9 +/- 7.8 years and 52% of the patients had diabetes. Complete sets of pre- and postprocedure GFRs were available in 21 patients. At 48 hours, there were no differences between the pre- and postprocedure GFRs. At the third week, one patient developed flu-like symptoms with severe gastroenteritis and was hospitalized for volume depletion. This patient initiated dialysis during the hospital stay. We conclude that at 48 hours, our cohort did not develop radiocontrast-induced nephropathy. During the 4-week phone call follow-up, only one patient needed dialysis. Large-scale studies with a longer follow-up using GFR estimation are needed to confirm these preliminary findings.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15934971     DOI: 10.1111/j.1525-139X.2005.18319.x

Source DB:  PubMed          Journal:  Semin Dial        ISSN: 0894-0959            Impact factor:   3.455


  6 in total

1.  Alprostadil protects type 2 diabetes mellitus patients treated with metformin from contrast-induced nephropathy.

Authors:  Jing Wang; Xiaobo Ai; Li Li; Yanyan Gao; Nina Sun; Changgui Li; Weihong Sun
Journal:  Int Urol Nephrol       Date:  2017-06-27       Impact factor: 2.370

Review 2.  Standardized definitions for hemodialysis vascular access.

Authors:  Timmy Lee; Michele Mokrzycki; Louise Moist; Ivan Maya; Miguel Vazquez; Charmaine E Lok
Journal:  Semin Dial       Date:  2011-09-09       Impact factor: 3.455

Review 3.  Vascular mapping: does it help to maximize fistulae placement?

Authors:  Vandana Dua Niyyar; Haimanot Wasse
Journal:  Adv Chronic Kidney Dis       Date:  2009-09       Impact factor: 3.620

4.  Letter to the Editor re: Are intravenous injections of contrast media really less nephrotoxic than intra-arterial injections?

Authors:  Piero Stratta; Cristina Izzo; Caterina Canavese; Marco Quaglia
Journal:  Eur Radiol       Date:  2013-02-01       Impact factor: 5.315

5.  Estimating the Risk of Radiocontrast-Associated Nephropathy.

Authors:  Emilee Wilhelm-Leen; Maria E Montez-Rath; Glenn Chertow
Journal:  J Am Soc Nephrol       Date:  2016-09-29       Impact factor: 10.121

6.  Vascular Access Practice Patterns in Canada: A National Survey.

Authors:  Chance Dumaine; Mercedeh Kiaii; Lisa Miller; Louise Moist; Matthew J Oliver; Charmaine E Lok; Swapnil Hiremath; Jennifer M MacRae
Journal:  Can J Kidney Health Dis       Date:  2018-02-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.